Dr. Drew A. Lansdown, M.D.
Orthopedic Surgery (Orthopaedic Surgery Physician)
- Medicare participating
At a glance
- Medical school
- University of Chicago, Pritzker School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 204
Licensed in California since 2012, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: University of Chicago, Pritzker School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Orthopaedic Surgery Physician primary
CA license A121573 (first issued 2012; current) -
Sports Medicine (Orthopaedic Surgery) Physician
IL license 036.140148 (first issued 2016; not renewed) · IN license 01076959A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCSF Medical Center San Francisco, CA
- UCSF Health Saint Francis Hospital San Francisco, CA
Medical groups
- University of California San Francisco (1,839 clinicians)
- UCSF Medical Group Business Services (1,598 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 204
- Services billed
- 441
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 178 | 125 |
| Established patient office or other outpatient visit, 20-29 minutes | 144 | 106 |
| New patient office or other outpatient visit, 45-59 minutes | 56 | 56 |
| Aspiration and/or injection of fluid from large joint | 55 | 43 |
| Prosthetic repair of shoulder joint, total shoulder | 16 | 16 |
| New patient office or other outpatient visit, 30-44 minutes | 15 | 15 |
| Removal of extensive shoulder joint tissue using an endoscope | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ibuprofen Other prescribers in San Francisco, CA | 28 |
| Ondansetron Hcl Other prescribers in San Francisco, CA | 22 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in San Francisco, CA | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 9 payments worth $630 in total to this clinician.
| Linvatec Corporation | $208 |
|---|---|
| Vericel Corporation | $117 |
| Arthrex, Inc. | $97.86 |
| Abanza Inc. | $89.87 |
| Evolution Surgical, Inc | $85.99 |
| Stryker Corporation | $31.20 |
| Food and Beverage | $630 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $10,141 in research payments for these studies, mostly to the institutions running them.
- Shoulder id primary reversed glenoid outcomes clinical study (sid study; UE-02-2021)
Stryker Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.